BMC Nephrology

Papers
(The H4-Index of BMC Nephrology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry disease92
Immunomodulatory effect of CD71+ erythroid cells in patients with kidney failure80
Sexually dimorphic response to tobacco in the development of chronic kidney disease: a systematic review76
Association between job characteristics and kidney function among men: a cross-sectional analysis of the Rafsanjan cohort study69
The relationship between multiple plasma biomarker levels and renal disease activity in Fabry disease55
SARS-CoV-2 in dialysis patients and the impact of vaccination54
Hypoxia-inducible factor-1 alpha and nuclear factor erythroid 2-related factor 2 as biomarkers of renal scarring in children with congenital anomalies of the kidney and urinary tract: a prospective ca52
Autonomic neuropathy in dialysis patients – investigations with a new symptom score (COMPASS 31)50
A potential link between AQP3 and SLC14A1 gene expression level and clinical parameters of maintenance hemodialysis patients49
The relationship between social support, psychological distress, and patient activation in peritoneal dialysis patients: a cross-sectional study47
Therapeutic strategies for olfactory impairment in patients with chronic kidney disease: a systematic review47
Clinical value of noninvasive lens advanced glycation end product detection in early screening and severity evaluation of patients with diabetic kidney disease44
A comparative study of postadrenalectomy hyperuricemia and renal impairment in patients with unilateral primary aldosteronism: does histopathology subtype matter?39
Risk factors associated with acute kidney injury in a pediatric intensive care unit in Addis Ababa Ethiopia: case-control study37
Transplant centers’ prophylaxis and monitoring strategies: a key determinant of current herpes and polyomavirus incidences – results from the DZIF kidney transplant cohort37
Correction to: Clinical covariates influencing clinical outcomes in primary membranous nephropathy37
Correction: Sodium zirconium cyclosilicate versus sodium polystyrene sulfonate for treatment of hyperkalemia in hemodialysis patients: a randomized clinical trial37
Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report36
Clinical features of COVID-19 among patients with end-stage renal disease on hemodialysis in the context of high vaccination coverage during the omicron surge period: a retrospective cohort study36
Late-onset renal TMA and tubular injury in cobalamin C disease: a report of three cases and literature review31
A young woman with membranoproliferative glomerulonephritis and persistent hypocomplementemia: a case report31
A very complicated UTI: malakoplakia following E. coli urinary tract infection30
Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study30
Diagnostic accuracy and clinical usefulness of erythrocyte creatine content to predict the improvement of anaemia in patients receiving maintenance haemodialysis30
Renometabolic disorder in experimental rat model of polycystic ovarian syndrome is reversed by acetate-mediated inhibition of pyruvate dehydrogenase kinase 430
Impact of occult renal dysfunction on postoperative acute kidney injury and late prognosis in elderly patients undergoing coronary artery bypass30
Serum and plasma levels of Ba, but not those of soluble C5b-9, might be affected by renal function in chronic kidney disease patients29
The outcome of thrombotic microangiopathy in kidney transplant recipients29
Patient monitoring in a pragmatic, multicenter trial of incremental hemodialysis: early experience from the TwoPlus randomized controlled trial28
0.22472214698792